Search research articles
Contact Us
Filters
Showing results (31-40 of 213) with videos related to
Page
of 22
Sort By:
Dermatology (Basel, Switzerland)
|
November 24, 2021
Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?
Eve Bédouelle, Jean Michel Nguyen, Emilie Varey, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 25, 2018
Female type of adult acne: Physiological and psychological considerations and management
Brigitte Dreno, Edileia Bagatin, Ulrike Blume-Peytavi, et al.
Bulletin Du Cancer
|
September 6, 2003
[Passive immunotherapy of melanoma]
Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
European Journal of Dermatology : EJD
|
January 7, 2020
Could anti-PD-1 be a therapeutic alternative for metastatic pleomorphic dermal sarcoma?
Barbara Bregeon, Marie-Laure Jullie, Hugues Begueret, et al.
European Journal of Dermatology : EJD
|
October 12, 2023
Long-term benefits of a therapeutic make-up consultation for patients with various facial dermatoses
Julia Bonnelye, Ugo Lancien, Alexandra Poinas, et al.
Cancers
|
October 13, 2021
Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases
Jean-Matthieu L'Orphelin, Emilie Varey, Amir Khammari, et al.
European Journal of Dermatology : EJD
|
June 25, 2008
Management of skin ageing: how to combine cosmetic procedures
Brigitte Dreno, Tanja Fischer, Elisabetta Perosino, et al.
European Journal of Dermatology : EJD
|
October 13, 2021
Interest in artificial intelligence for the diagnosis of non-melanoma skin cancer: a survey among French general practitioners
Romain Samaran, Jean-Matthieu L'Orphelin, Brigitte Dreno, et al.
Experimental Dermatology
|
April 29, 2016
Effect of indoleamine 2,3-dioxygenase expressed by foetal fibroblasts on melanoma cells
Cécile Frenard, Anne-Chantal Knol, Marie Lemoigne, et al.
The Oncologist
|
July 9, 2014
Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma
Brigitte Dreno, Nicole Basset-Seguin, Ivor Caro, et al.
Page
of 22
Search research articles
Search
Showing results (31-40 of 213) with videos related to
Sort By:
Page
of 22
Dermatology (Basel, Switzerland)
|
November 24, 2021
Should Targeted Therapy Be Continued in BRAF-Mutant Melanoma Patients after Complete Remission?
Eve Bédouelle, Jean Michel Nguyen, Emilie Varey, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 25, 2018
Female type of adult acne: Physiological and psychological considerations and management
Brigitte Dreno, Edileia Bagatin, Ulrike Blume-Peytavi, et al.
Bulletin Du Cancer
|
September 6, 2003
[Passive immunotherapy of melanoma]
Francine Jotereau, Nathalie Labarriere, Nadine Gervois, et al.
European Journal of Dermatology : EJD
|
January 7, 2020
Could anti-PD-1 be a therapeutic alternative for metastatic pleomorphic dermal sarcoma?
Barbara Bregeon, Marie-Laure Jullie, Hugues Begueret, et al.
European Journal of Dermatology : EJD
|
October 12, 2023
Long-term benefits of a therapeutic make-up consultation for patients with various facial dermatoses
Julia Bonnelye, Ugo Lancien, Alexandra Poinas, et al.
Cancers
|
October 13, 2021
Severe Late-Onset Grade III-IV Adverse Events under Immunotherapy: A Retrospective Study of 79 Cases
Jean-Matthieu L'Orphelin, Emilie Varey, Amir Khammari, et al.
European Journal of Dermatology : EJD
|
June 25, 2008
Management of skin ageing: how to combine cosmetic procedures
Brigitte Dreno, Tanja Fischer, Elisabetta Perosino, et al.
European Journal of Dermatology : EJD
|
October 13, 2021
Interest in artificial intelligence for the diagnosis of non-melanoma skin cancer: a survey among French general practitioners
Romain Samaran, Jean-Matthieu L'Orphelin, Brigitte Dreno, et al.
Experimental Dermatology
|
April 29, 2016
Effect of indoleamine 2,3-dioxygenase expressed by foetal fibroblasts on melanoma cells
Cécile Frenard, Anne-Chantal Knol, Marie Lemoigne, et al.
The Oncologist
|
July 9, 2014
Clinical benefit assessment of vismodegib therapy in patients with advanced basal cell carcinoma
Brigitte Dreno, Nicole Basset-Seguin, Ivor Caro, et al.
Page
of 22